|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▼
|
Registration date ▲
|
Status ▲
|
|
REMDESIVIR |
J05AB16 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005622 |
03-07-2020 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
RIPRETINIB |
L01EX19 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005614 |
18-11-2021 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
ASCIMINIB |
L01EA06 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
ARTESUNATE |
P01BE03 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005550 |
22-11-2021 |
VALID
|
|
MITAPIVAT |
B06AX04 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
AVACOPAN |
L04AJ05 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
FR
|
I
|
14-11-2023 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
INDACATEROL, GLYCOPYRRONIUM BROMIDE AND MOMETASONE |
R03AL12 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005518 |
03-07-2020 |
VALID
|
|
INDACATEROL AND MOMETASONE |
R03AK14 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005516 |
30-05-2020 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
TOFERSEN |
N07XX22 |
FR
|
I
|
29-10-2024 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
VOSORITIDE |
M05BX07 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005475 |
26-08-2021 |
VALID
|
|
AMIVANTAMAB |
L01FX18 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005454 |
09-12-2021 |
VALID
|
|
ABROCITINIB |
D11AH08 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005452 |
09-12-2021 |
VALID
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
EVINACUMAB |
C10AX17 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
FR
|
I
|
14-05-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
PRALSETINIB |
L01EX23 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
DUVELISIB |
L01EM04 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005378 |
15-09-2022 |
VALID
|
|
CENOBAMATE |
N03AX25 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005377 |
26-03-2021 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
LASMIDITAN |
N02CC08 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005332 |
17-08-2022 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
VERICIGUAT |
C01DX22 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
FR
|
I
|
30-05-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
ACALABRUTINIB |
L01EL02 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005299 |
05-11-2020 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
FR
|
I
|
25-04-2022 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005271 |
18-07-2022 |
VALID
|
|
IVACAFTOR, TEZACAFTOR AND ELEXACAFTOR |
R07AX32 |
FR
|
I
|
03-03-2021 |
EMEA/H/C/005269 |
21-08-2020 |
VALID
|
|
TUCATINIB |
L01EH03 |
FR
|
I
|
12-10-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
FR
|
I
|
27-02-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
